Ipsen
Description Ipsen S.A. engages in the research, development, manufacture, and sale of pharmaceutical products worldwide. The company offers drugs in the areas of uro-oncology, endocrinology, neurology, hematology, gastroenterology, cardiovascular, cognitive disorders, primary care, and specialty care. Its product portfolio comprises Decapeptyl, a peptide formulation for injection to treat advanced prostate cancer; Hexvix that is used for the detection of bladder cancer; Somatuline and Somatuline Autogel, which are sustained release formulations for injection of a somatostatin analogue peptide for the treatment of acromegaly and neuroendocrine tumors; and NutropinAq, a liquid formulation for the treatment of growth failure in children and growth hormone deficiency in adults; and Increlex, a formulation for injection for a twice daily use of human recombinan, as well as used for the treatment of growth failure in children and adolescents with severe primary insulin-like growth factor 1 deficiency. The companys products also consist of Dysport, a botulinum neurotoxin type A complex to treat spasticity of upper limbs following a stroke, as well as spasticity of other muscles; Apokyn for the treatment of off episodes associated with advanced Parkinsons disease; Smecta, a natural clay-based drug for chronic and acute diarrhoea; Forlax for the treatment of constipation; Tanakan, an oral formulation of EGb 761 to treat age-related cognitive disorders; and Nisis and Nisisco, which are oral formulations that contain valsartan for the treatment of hypertension. Its co-promoted products comprise Adenuric for the treatment of gout and chronic hyperuricaemia; and Exforg to treat hypertension. Ipsen has a strategic partnership with Inspiration Biopharmaceuticals Inc., as well as strategic collaborations with Photocure and Syntaxin. The company was founded in 1929 and is headquartered in Boulogne-Billancourt, France. Ipsen S.A. is a subsidiary of Mayroy S.A. To view the detailed information, you need to SUBSCRIBE with us. |
 |